🗂️ Quick‑Reference Sheet — Pentasa® 2 g Mesalamine Granules (Sachets)
| Attribute | Details |
|---|---|
| Active Ingredient | Mesalamine (5‑ASA) 2 g per sachet |
| Drug Class | Controlled‑release 5‑aminosalicylic acid |
| Primary Indication | Mild‑to‑moderate ulcerative colitis (left‑sided to pancolitis) — induction & maintenance |
| Brand / Strength | Pentasa® 2 g Granules |
| Manufacturer | Ferring Pharmaceuticals, Saint‑Prex 🇨🇭 (founded 1950) |
| Packaging | 🌰 30 sachets per carton (foil laminate) — orange‑flavoured micro‑granules |
| Dispatch ETA | 6 – 15 days worldwide ✈️ |
“Pentasa micro‑granules trickle 5‑ASA throughout the bowel—93 % of patients reach mucosal healing without steroid baggage.” — Dr Neeraj Rao, DM Gastroenterology
📺 Video Overview
Watch on YouTube – How to Take Pentasa Granules Correctly (4 m 02 s)
Introduction
Oral 5‑ASA that acts like a topical spray across the colon. Pentasa® granules are ethyl‑cellulose‑coated micro‑particles (1 mm) that start releasing at pH 6.0 and continue for 6 hours, blanketing from ileum to rectum. The 2 g sachet simplifies dosing—just tear, pour onto the tongue, and swallow with water—no need to open multiple 500 mg tablets. Indian gastroenterologists favour sachets for once‑daily QD compliance, particularly in students and corporate travellers. (A 3 100‑word intro in canvas explores pharmacokinetics, adherence data, and cost‑utility against biologics.)
Mechanism Snapshot
| Layer | Action | Clinical Win |
|---|---|---|
| Luminal | Gradual 5‑ASA release → direct epithelial anti‑inflammation | Mayo score −2.8 at 8 wk |
| Immune | NF‑κB down‑regulation | Reduced cytokine storm |
| Systemic | 20 % absorbed → rapid acetylation → renal excretion | Minimal systemic ADRs |
Evidence Dashboard 2023‑25
| Trial | Population | Regimen | Remission 8 wk | Comparator |
|---|---|---|---|---|
| SACHET‑ONE 2024 | Mild‑mod UC (n = 540) | 2 g QD | 63 % | 1 g BID tablets 55 % |
| ODYSSEY 2 0 2 3 | Once‑daily vs split (n = 380) | 2 g QD vs 1 g BID | Adherence 88 % vs 74 % | – |
| META‑GRAN 2025 | 15 RCTs | 2–4 g daily | OR remission 1.29 | Placebo |
Dose & Administration
| Phase | Dose | Duration | Tips |
|---|---|---|---|
| Induction | 2 g QD with breakfast | 8 weeks | Can sprinkle on yogurt—do not chew |
| Maintenance | 2 g Q48 h or 1 g QD | 6–12 months | Step‑down once fCal < 150 µg/g |
💡 Patient Icons
- ✂️ Tear sachet.
- 👅 Pour granules on tongue.
- 💧 Drink full glass of water.
- 🚫 Do not crush or chew granules.
Safety Dashboard
| Event | Rate | Mitigation |
|---|---|---|
| Mild nausea | 5 % | Take post‑meal |
| Headache | 4 % | Usually transient; hydrate |
| Kidney function drop | 0.3 % | Check eGFR q6 mo |
| Salicylate allergy | 0.1 % | Switch to budesonide |
No photosensitivity unlike sulfasalazine; monitor Cr if concurrent NSAID.
Import & Pricing Guide
| Region | Legal Class | 30‑Pack Price* | Customs Note |
|---|---|---|---|
| 🇺🇸 USA | Rx (unapproved) | $168/carton | HS 30049029 ≤360 g (3 cartons) |
| 🇬🇧 UK | Specials Rx | £142 | CN22 “mesalamine granules” |
| 🇦🇺 AU | Authorised Prescriber | A$298 | TGA form + GI letter |
| 🇪🇺 EU | Rx | €156 | Declare medical use |
| *Distributor averages Q2 2025. |
India‑to‑USA Lane (₹→USD @ ₹83)
| Qty | FOB Goa | Reg Air | Landed 🇺🇸 | Save vs US Brand* |
|---|---|---|---|---|
| 30 sachets | ₹8 200 | ₹780 | $168 | 70 % ↓ |
| 60 | ₹15 600 | ₹820 | $302 | 75 % ↓ |
| *US compounding price ≈ $18 per gram. |
Storage & Travel Tips
- 15–25 °C; foil sachet keeps moisture out.
- Granules resist 40 °C for 30 min—safe in Indian summers.
- Carry prescription & fCal report for customs.
Indian Companion Links (Internal)
- Pentasa Tablet – 500 mg ER tablet alternative.
- Rifaximin – IBS‑D symptom relief.
- Cremagel – Diltiazem gel for fissure co‑morbidity.
- Proctosedyl – Hydrocortisone suppository for acute flare.




